CRAB (ALK-Abello, Inc.)


Welcome to the PulseAid listing for the CRAB drug offered from ALK-Abello, Inc.. This pharmaceutical is classified as a NON-STANDARDIZED ALLERGENIC. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same NON-STANDARDIZED ALLERGENIC drug type category.
LABELER NAME / MANUFACTURER: ALK-Abello, Inc.
NON-PROPRIETARY NAME: RED KING CRAB
SUBSTANCE NAME: RED KING CRAB
TYPE: NON-STANDARDIZED ALLERGENIC
PHARMA CLASS:
ROUTE: PERCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1998-02-23
END MARKETING DATE: 0000-00-00


CRAB NON-STANDARDIZED ALLERGENIC Details:

Item DescriptionCRAB from ALK-Abello, Inc.
LABELER NAME: ALK-Abello, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.1(mg/mL)
START MARKETING DATE: 1998-02-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0268-6130_26681b50-ec54-402a-bef2-409d1350340d
PRODUCT NDC: 0268-6130
APPLICATION NUMBER: BLA103753

Other RED KING CRAB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALK-Abello, Inc.CRAB